Literature DB >> 7037826

Defective cellular immune response in vitro in common variable immunodeficiency.

S Cunningham-Rundles, C Cunningham-Rundles, F P Siegal, S Gupta, E M Smithwick, C Kosloff, R A Good.   

Abstract

Mononuclear cells from 39 patients with hypogammaglobulinemia of the common variable type were analyzed for in vitro proliferative response to a panel of cell activators in order to examine the lymphocyte response to mitogens and to study the capacity to generate an immunologically specific secondary response. Patient lymphocyte response to phytohemagglutinin and concanavalin A was found to be significantly lower than that of controls studied in parallel (P less than 0.01), and low response did not correlate with T-lymphocyte number. Response to pokeweed mitogen was significantly lower than that of controls (P less than 0.01), but response to zinc, tested in a few patients, was normal. Strong depressions of patient lymphocyte proliferative responses to Candida albicans, Escherichia coli, and Staphylococcus aureus were observed (P less than 0.01); all of these microbial activators require intact B-cell function for maximum response. Repeated testing of individual patients indicated that poor lymphocyte response could be consistently observed. Examination of change in vitro lymphocyte response during clinical course and disease management showed that a consistent pattern of intrinsic lymphocyte functional deficiency could be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7037826     DOI: 10.1007/bf00915478

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  24 in total

1.  A clinical and experimental study of agammaglobulinemia.

Authors:  R A GOOD; R L VARCO
Journal:  J Lancet       Date:  1955-06

2.  T-cell regulation of immunoglobulin synthesis and proliferation in pokeweed (Pa-1)-stimulated human lymphocyte cultures.

Authors:  G Janossy; E Gomez de la Concha; A Luquetti; M J Snajdr; M J Waxdal; T A Platts-Mills
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

3.  Zinc-induced activation of human B lymphocytes.

Authors:  S Cunningham-Rundles; C Cunningham-Rundles; B Dupont; R A Good
Journal:  Clin Immunol Immunopathol       Date:  1980-05

4.  Suppression of B-cell differentiation by leukocytes from hypogammaglobulinemic patients.

Authors:  F P Siegal; M Siegal; R A Good
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

5.  Impaired proliferative response to B-lymphocyte activators in common variable immunodeficiency.

Authors:  S Cunningham-Rundles; C Cunningham-Rundles; D I Ma; F P Siegal; S Gupta; E M Smithwick; C Kosloff; R A Good
Journal:  Scand J Immunol       Date:  1982-03       Impact factor: 3.487

6.  Protein A-positive staphylococci serve as a selective B cell mitogen for lymphocytes from primary immunodeficiency patients.

Authors:  M C Sirianni; F Pandolfi; F Aiuti; H Wigzell
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

7.  B lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with antibody-deficiency states.

Authors:  E R Pearl; L B Vogler; A J Okos; W M Crist; A R Lawton; M D Cooper
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

8.  Reversible dysfunction of T-lymphocytes in common variable immunodeficiency.

Authors:  W H Marshall; P W Allderdice; H W Edstrom; R M Newton; E Pike
Journal:  Can Med Assoc J       Date:  1977-06-04       Impact factor: 8.262

9.  Hypoimmunoglobulinaemia with deficiency of pre-B cells.

Authors:  A R Hayward
Journal:  Lancet       Date:  1978-05-13       Impact factor: 79.321

Review 10.  Selective triggering of human T and B lymphocytes in vitro by polyclonal mitogens.

Authors:  M Greaves; G Janossy; M Doenhoff
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Experimental approaches to nutrition and cancer: fats, calories, vitamins and minerals.

Authors:  R A Good; E Lorenz; R Engelman; N K Day
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

2.  Large cell lymphoma presenting as a flare of colitis in a patient with common variable immune deficiency.

Authors:  Megan Dunnigan; Harris Yfantis; Aaron P Rapoport; Keya Hosseinzadeh; Christopher D Gocke; Raymond K Cross
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.199

3.  Clinical and immunologic analyses of 103 patients with common variable immunodeficiency.

Authors:  C Cunningham-Rundles
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

4.  Increased IL-6 gene expression and production in patients with common variable immunodeficiency.

Authors:  F Pandolfi; R Paganelli; A Oliva; I Quinti; V Polidori; E Fanales-Belasio; E Guerra; F Aiuti
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

5.  Polyclonal and antigen-specific B-cell responses in patients with common variable immunodeficiency.

Authors:  S G Pahwa; M K Hoffman; R N Pahwa; R A Good
Journal:  J Clin Immunol       Date:  1982-07       Impact factor: 8.317

6.  Lymphocyte subpopulations in primary immunodeficiency disorders.

Authors:  S Gupta
Journal:  Indian J Pediatr       Date:  1982 May-Jun       Impact factor: 1.967

7.  Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens.

Authors:  G Pastorelli; M G Roncarolo; J L Touraine; G Peronne; P A Tovo; J E de Vries
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

8.  Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency.

Authors:  G Kruger; K Welte; N Ciobanu; C Cunningham-Rundles; P Ralph; S Venuta; S Feldman; B Koziner; C Y Wang; M A Moore
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

9.  Autoimmune manifestations in common variable immunodeficiency.

Authors:  Stavroula Giannouli; Dimitra Anagnostou; Fotini Soliotis; Michalis Voulgarelis
Journal:  Clin Rheumatol       Date:  2004-06-18       Impact factor: 2.980

10.  Immunophenotypical alterations in a subset of patients with common variable immunodeficiency (CVID).

Authors:  E Baumert; G Wolff-Vorbeck; M Schlesier; H H Peter
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.